Reaching high-risk Black adults for diabetes prevention programming during a pandemic: The design of Fit & Faithful a randomized controlled community trial.
Reaching high-risk Black adults for diabetes prevention programming during a pandemic: The design of Fit & Faithful a randomized controlled community trial.
复制标题
DOI:
10.1016/j.cct.2022.106973
复制
发表时间:
2022-12
影响因子:
2.2
通讯作者:
Kriska AM
中科院分区:
文献类型:
--
作者:
Williams LB;Moser DK;Gustafson A;Waters TM;Rayens MK;Karle ER;Kriska AM
Obesity is a key risk factor for Type 2 diabetes (T2D). Alarmingly, 87% of US adults have overweight or obesity, with non-Hispanic black adults having higher obesity and T2D prevalence than non-Hispanic white. The Diabetes Prevention Program (DPP) demonstrated the clinical benefits of lifestyle intervention (LI). While the DPP LI is effective, some participants don’t achieve clinically significant weight loss in the current group-based translation paradigm. Black adults have the lowest adjusted weight loss (3.2%) among all racial/ethnic groups. Early intervention nonresponse defined as ≤1% weight loss at intervention week 4 is linked to lower probability of achieving weight loss goals. This paper describes the design and methods of a cluster randomized controlled trial among black weight loss nonresponders nested in 20 community sites (primarily churches). Descriptions of the adaptations made to transition the program to virtual format during the COVID-19 pandemic are also included. Trained community health workers deliver a group-based, 6-month long DPP over 18 sessions via Zoom. Additionally, nonresponders in the enhanced group receive weekly telephone support to provide individual-level intervention to help overcome weight loss barriers. Outcomes include weight, physical activity level, blood pressure, and dietary behaviors; these are compared between nonresponders in the enhanced intervention group and nonresponders in the active control group. Cost, mediators, and moderators are explored. If found to efficacious, these enhanced strategies could be standardized as a supplement for use with DPP nonresponders.
登录
查看更多内容
影响因子:
37.8
作者:
Jensen MD;Ryan DH;Apovian CM;Ard JD;Comuzzie AG;Donato KA;Hu FB;Hubbard VS;Jakicic JM;Kushner RF;Loria CM;Millen BE;Nonas CA;Pi-Sunyer FX;Stevens J;Stevens VJ;Wadden TA;Wolfe BM;Yanovski SZ;Jordan HS;Kendall KA;Lux LJ;Mentor-Marcel R;Morgan LC;Trisolini MG;Wnek J;Anderson JL;Halperin JL;Albert NM;Bozkurt B;Brindis RG;Curtis LH;DeMets D;Hochman JS;Kovacs RJ;Ohman EM;Pressler SJ;Sellke FW;Shen WK;Smith SC Jr;Tomaselli GF;American College of Cardiology/American Heart Association Task Force on Practice Guidelines;Obesity Society
通讯作者:
Obesity Society
影响因子:
158.5
作者:
Knowler, WC;Barrett-Connor, E;Nathan, DM
通讯作者:
Nathan, DM
影响因子:
5
作者:
COHEN, S;KAMARCK, T;MERMELSTEIN, R
通讯作者:
MERMELSTEIN, R
影响因子:
3.1
作者:
Carels, Robert A.;Wott, Carissa B.;Koball, Afton
通讯作者:
Koball, Afton
DOI:
10.1249/01.mss.0000218138.91812.f9
发表时间:
2006-05-01
期刊:
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE
影响因子:
--
作者:
Kriska, Andrea M.;Edelstein, Sharon L.;Regensteiner, Judith G.
通讯作者:
Regensteiner, Judith G.